Sfoglia per AUTORE
CICERI F
Collezione AO Cuneo

  

Items : 18

Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study. in Bone marrow transplantation / Bone Marrow Transplant. 2022 May;57(5):834-836. doi: 10.1038/s41409-022-01618-5. Epub 2022 Feb 24.

2022
AO Cuneo
AOU Città della Salute di Torino
ASL Città di Torino

Bonifazi F; Ciceri F; Irrera G; Fanin R; Sorasio R; Iori AP; Bresciani P; Arcese W; Busca A; Dubbini MV; Candoni A; Rambaldi A; Lazzarotto D;

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Jun;57(6):949-958. doi: 10.1038/s41409-022-01626-5. Epub 2022 Apr 12.

2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Alessandria

Ciceri F; Grassi A; Bruno B; Rambaldi A; Vacca A; Vallisa D; Sacchi N; Oldani E; Masciulli A; Onida F; Palazzo G; Parma M; Tringali S; Martino M; Gheorghiu A; Girmenia C; Chiusolo P; Cupri A; Luppi M; Nozzoli C; Baronciani D; Casini M; Musso M; Grillo G; Carluccio P; Sorasio R; Cilloni D; Picardi A; Proia A; et alii...

Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):857-863. doi: 10.1002/hon.3060. Epub 2022 Aug 14.

2022
ASL Cuneo 1
ASL Città di Torino
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Passamonti F; Corradini P; Fabbri E; Coviello E; Ruggeri M; Ferrero D; Venditti A; Romano I; Gentile M; Mecucci C; Gherlinzoni F; Mohamed S; Krampera M; Marchetti M; Massaia M; Arcaini L; Sacchi MV; Guidetti A; Ciceri F; Cairoli R; Monaco F; Lanza F;

Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06. in Haematologica / Haematologica. 2021 Oct 1;106(10):2578-2587. doi: 10.3324/haematol.2020.252825.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Spinelli O; Pavoni C; Bassan R; Cortelezzi A; Falini B; Todisco E; Bernardi M; Campiotti L; Ciceri F; Mattei D; Corradini P; Scattolin AM; Cavattoni I; Tajana M; Ferrero D; Audisio E; Terruzzi E; De Paoli L; Cattaneo C; Borlenghi E; Mannelli F; Gianfaldoni G; Grassi A; Delaini F; Oldani E; Intermesoli T; Michelato A; Elidi L; et alii...

Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti. in Transplantation and cellular therapy / Transplant Cell Ther. 2021 May;27(5):406.e1-406.e11. doi: 10.1016/j.jtct.2020.11.021. Epub 2021 Feb

2021
AO Cuneo
AOU Città della Salute di Torino

Bonifazi F; Ciceri F; Miccichè S; Mangione I; Pollichieni S; Mammoliti S; Gallina AM; Patriarca F; Carella AM; Luppi M; Olivieri A; Martino M; Carluccio P; Celeghini I; Andreani M; Lamparelli T; La Rocca U; Milone G; Chiusolo P; Borghero C; Papalinetti G; Guidi S; Saporiti G; Zallio F; Fagioli F; Farina L; Russo D; Arcese W; Benedetti F; et alii...

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Tognoni G; Finazzi MC; Bellini M; Bucelli C; Lunghi F; Vianelli N; Scaffidi L; Betti S; Guglielmelli P; Loscocco GG; Mora B; Cacciola E; Mannarelli C; Patriarca A; Cascavilla N; Rumi E; Siragusa S; Musolino C; Caramella M; Rapezzi D; Ricco A; Carli G; Palandri F; Pane F; Benevolo G; Bonifacio M; Iurlo A; Ciceri F; Ghirardi A; et alii...

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07. in Blood cancer journal / Blood Cancer J. 2020 Nov 13;10(11):119. doi: 10.1038/s41408-020-00383-2.

2020
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Rambaldi A; Masciulli A; Oldani E; Depaoli L; Bernardi M; Scattolin AM; Fracchiolla N; Ciceri F; Cortelezzi A; Mattei D; Romani C; Cavattoni I; Fumagalli M; Borlenghi E; Cortelazzo S; Audisio E; Marmont F; Cattaneo C; Tosi M; Spinelli O; Intermesoli T; Pavoni C; Bassan R;

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). in Cancers / Cancers (Basel). 2020 Aug 11;12(8):2242. doi: 10.3390/cancers12082242.

2020
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Spinelli O; Rambaldi A; Bassan R; Fracchiolla N; Corradini P; Campiotti L; Todisco E; Scattolin A; Ciceri F; Tajana M; Mattei D; Cavattoni I; Borlenghi E; De Paoli L; Audisio E; Terruzzi E; Gianfaldoni G; Oldani E; Lussana F; Intermesoli T; Caprioli C; Stefanoni P; Buklijas K; Elidi L; Michelato A; Salmoiraghi S; Pavoni C; Zanghì P; Cavagna R; et alii...

Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO). in Frontiers in oncology / Front Oncol. 2020 Oct 15;10:572918. doi: 10.3389/fonc.2020.572918. eCollection 2020.

2020
AOU Città della Salute di Torino
AO Cuneo

Ciceri F; Bruno B; Micò C; Fanin R; Borghero C; Musso M; Mordini N; Cavattoni I; Sorasio R; Saporiti G; Arcese W; Isola M; Picardi A; Mammoliti S; Oldani E; Lorentino F; Patriarca F; Sperotto A; Bonifazi F;

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial. in Haematologica / Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Tarella C; Ladetto M; Corradini P; Passera R; Gianni AM; Rambaldi A; Billio A; Gueli A; Mantoan B; Angrilli F; Perrone T; Semenzato G; Lanza F; Parvis G; Dondi A; Narni F; Zallio F; Zoli V; Devizzi L; Tucci A; Rota-Scalabrini D; Di Raimondo F; Stelitano C; Ciceri F; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; et alii...

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO). in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2019 Dec;25(12):2388-2397. doi: 10.1016/j.bbmt.2019.07.037. Epub 2019

2019
AO Cuneo
AOU Città della Salute di Torino
ASL Torino 4

Bonifazi F; Mammoliti S; Oldani E; Leotta S; Cortelezzi A; Risitano AM; Orciuolo E; Vacca A; Sorasio R; Dominietto A; Tecchio C; Olivieri A; Carella AM; Malagola M; Albano F; Zallio F; Mancini S; Irrera G; Santarone S; Colombo AA; Tringali S; Iori AP; Diral E; Zucchetti E; Perruccio K; Sica S; Picardi A; Busca A; Giglio F; et alii...

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. in Blood advances / Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625.

2019
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Falini B; Bosi A; Cortelazzo S; Audisio E; Oldani E; Spinelli O; Zanghì P; Ferrero D; Cortelezzi A; Corradini P; Campiotti L; Scattolin AM; Todisco E; Bernardi M; Borlenghi E; Ciceri F; Cattaneo C; De Paoli L; Cavattoni I; Mattei D; Terruzzi E; Marmont F; Gianfaldoni G; Boschini C; Pavoni C; Masciulli A; Bassan R; Intermesoli T; Pogliani EM; et alii...

Molecular prolife by next generation sequencing of acute myeloid leukemia with normal karyotype: Clinical results from the prospective trial 02/06 of the Northern Italy leukemia group (NILG) in Haematologica

2018
AO Cuneo
AOU Alessandria

Spinelli O; Salmoiraghi S; Zanghi P; Cavagna R; Michelato A; Buklijas K; Zannino L; Intermesoli T; Lussana F; Delaini F; Oldani E; Caprioli C; Stefanoni P; Gianfaldoni G; Marmont F; Ferrero D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Cavattoni I; Tajana M; Scattolin AM; Mattei D; Corradini P; Campiotti L; Ciceri F; Bernardi M; Todisco E; et alii...

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? in Expert opinion on biological therapy / Expert Opin Biol Ther. 2017 Jul;17(7):821-836. doi: 10.1080/14712598.2017.1324567. Epub 2017 May 22.

2017
AO Cuneo
AOU Città della Salute di Torino

Bruno B; Bonifazi F; Rambaldi A; Baccarani M; Fanin R; Ciceri F; Corradini P; Bassan R; Zaja F; Risitano A; Volpetti S; Festuccia M; Greco R; Peccatori J; Mordini N; Maino E; Mussetti A; Sarina B; Montefusco V; Patriarca F; Giaccone L; Onida F; Castagna L;

Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2016 Nov;22(11):1983-1987. doi: 10.1016/j.bbmt.2016.07.021. Epub 2016

2016
AOU Città della Salute di Torino
AO Cuneo

Rambaldi A; Bassan R; Romani C; Borlenghi E; Terruzzi E; Mattei D; Ciceri F; Mannelli F; Scattolin AM; Cortelezzi A; Cavattoni IM; Angelucci E; Raimondi R; Cattaneo C; Audisio E; Grassi A; Parolini M; Tosi M; Spinelli O; Oldani E; Masciulli A; Boschini C; Gianni F; Intermesoli T; Lussana F;

Sequential high-dose cytarabine plus idarubicin improves remission rate and survival duration in adult acute myelogenous leukemia (AML): Randomized trial of the Northern Italy leukemia group (NILG) in Haematologica

2016
AOU Alessandria
AO Ordine Mauriziano
AO Cuneo

Bassan R; Intermesoli T; Masciulli A; Boschini C; Gianfaldoni G; Marmont F; Cavattoni I; Mattei D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Ciceri F; Bernardi M; Scattolin AM; Todisco E; Campiotti L; Corradini P; Cortelezzi A; Tajana M; Ferrero D; Cignetti A; Marfisi RM; Delaini F; Zanghì P; Oldani E; Spinelli O; Audisio E; Cortelazzo S; et alii...

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia. in Blood cancer journal / Blood Cancer J. 2014 Jul 11;4(7):e225. doi: 10.1038/bcj.2014.48.

2014
AO Cuneo

Mattei D; Rambaldi A; Audisio E; Gianfaldoni G; Ciceri F; Cortelezzi A; Scattolin AM; Romani C; Cassibba V; Di Bona E; Borlenghi E; Intermesoli T; Pogliani EM; Peruta B; Tosi M; Oldani E; Bassan R; Spinelli O;

The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: A study from the Gruppo Italiano Trapianto di Midollo Osseo in Human Pathology

2011
AO Cuneo

Massi D; Fondi C; Nozzoli C; Benemei S; Lapi F; Albarello L; Avellini C; Bonoldi E; Casini M; Cesinaro AM; Ciceri F; Colombetti V; Comin CE; Donelli A; Fortunato M; Fratoni S; Guidi S; Messerini L; Milone G; Rapezzi D; Negri G; Patriarca F; Peccatori FA; Ponzoni M; Rafaniello P; Raimondi R; Salomone E; Tendas A; Villari L; et alii...